We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
In the latest trading session, Thermo Fisher Scientific (TMO - Free Report) closed at $510.15, marking a +0.1% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.04%. At the same time, the Dow lost 0.22%, and the tech-heavy Nasdaq gained 2.93%.
Coming into today, shares of the maker of scientific instrument and laboratory supplies had lost 0.89% in the past month. In that same time, the Medical sector gained 2.28%, while the S&P 500 gained 4.22%.
Wall Street will be looking for positivity from Thermo Fisher Scientific as it approaches its next earnings report date. On that day, Thermo Fisher Scientific is projected to report earnings of $5.43 per share, which would represent a year-over-year decline of 1.45%. Meanwhile, our latest consensus estimate is calling for revenue of $10.99 billion, up 0.2% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $23.69 per share and revenue of $45.3 billion, which would represent changes of +1.94% and +0.86%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Thermo Fisher Scientific. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.01% higher. Thermo Fisher Scientific is currently a Zacks Rank #3 (Hold).
Investors should also note Thermo Fisher Scientific's current valuation metrics, including its Forward P/E ratio of 21.51. For comparison, its industry has an average Forward P/E of 30.46, which means Thermo Fisher Scientific is trading at a discount to the group.
It is also worth noting that TMO currently has a PEG ratio of 2.53. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. TMO's industry had an average PEG ratio of 2.52 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 112, putting it in the top 45% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
In the latest trading session, Thermo Fisher Scientific (TMO - Free Report) closed at $510.15, marking a +0.1% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.04%. At the same time, the Dow lost 0.22%, and the tech-heavy Nasdaq gained 2.93%.
Coming into today, shares of the maker of scientific instrument and laboratory supplies had lost 0.89% in the past month. In that same time, the Medical sector gained 2.28%, while the S&P 500 gained 4.22%.
Wall Street will be looking for positivity from Thermo Fisher Scientific as it approaches its next earnings report date. On that day, Thermo Fisher Scientific is projected to report earnings of $5.43 per share, which would represent a year-over-year decline of 1.45%. Meanwhile, our latest consensus estimate is calling for revenue of $10.99 billion, up 0.2% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $23.69 per share and revenue of $45.3 billion, which would represent changes of +1.94% and +0.86%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Thermo Fisher Scientific. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.01% higher. Thermo Fisher Scientific is currently a Zacks Rank #3 (Hold).
Investors should also note Thermo Fisher Scientific's current valuation metrics, including its Forward P/E ratio of 21.51. For comparison, its industry has an average Forward P/E of 30.46, which means Thermo Fisher Scientific is trading at a discount to the group.
It is also worth noting that TMO currently has a PEG ratio of 2.53. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. TMO's industry had an average PEG ratio of 2.52 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 112, putting it in the top 45% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.